Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Target Raised at UBS Group

Sabra Healthcare REIT (NASDAQ:SBRA) had its target price raised by UBS Group from $20.00 to $22.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently has a neutral rating on the real estate investment trust’s stock.

A number of other research firms have also issued reports on SBRA. Wells Fargo & Company dropped their target price on Sabra Healthcare REIT from $23.00 to $21.00 and set an “overweight” rating on the stock in a report on Monday, October 19th. Truist Financial lifted their price objective on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. Deutsche Bank reissued a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Barclays dropped their price objective on shares of Sabra Healthcare REIT from $23.00 to $21.00 and set an “equal weight” rating on the stock in a research note on Tuesday, October 13th. Finally, Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research report on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $21.67.

Sabra Healthcare REIT Trading Down 1.6%

NASDAQ:SBRA opened at $20.97 on Wednesday. The company has a market capitalization of $5.49 billion, a PE ratio of 74.90, a P/E/G ratio of 1.86 and a beta of 0.68. Sabra Healthcare REIT has a 52-week low of $17.53 and a 52-week high of $22.77. The stock’s 50 day moving average price is $19.90 and its 200 day moving average price is $20.03. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.86.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.05). The company had revenue of $249.57 million during the quarter, compared to analyst estimates of $236.64 million. Sabra Healthcare REIT had a net margin of 7.78% and a return on equity of 2.55%. The business’s revenue was up 31.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.38 EPS. On average, research analysts anticipate that Sabra Healthcare REIT will post 1.52 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be paid a $0.30 dividend. The ex-dividend date is Friday, November 13th. This represents a $1.20 annualized dividend and a dividend yield of 5.7%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 428.57%.

Insiders Place Their Bets

In other Sabra Healthcare REIT news, CEO Richard Matros sold 200,000 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,657,686 shares of the company’s stock, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.09% of the company’s stock.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of hedge funds and other institutional investors have recently modified their holdings of SBRA. Advisors Asset Management Inc. acquired a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth approximately $3,463,000. Private Advisor Group LLC purchased a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth about $811,000. Ieq Capital LLC purchased a new position in shares of Sabra Healthcare REIT during the 3rd quarter worth approximately $1,534,000. Focus Advisor Solutions LLC acquired a new position in shares of Sabra Healthcare REIT in the third quarter worth $351,000. Finally, Global Retirement Partners LLC lifted its holdings in Sabra Healthcare REIT by 7.7% in the 3rd quarter. Global Retirement Partners LLC now owns 7,080 shares of the real estate investment trust’s stock valued at $140,000 after purchasing an additional 505 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.